PRIM-DJ2727
Sponsors
The University of Texas Health Science Center, Houston
Conditions
Adults With Ulcerative ColitisBloatingClostridium DifficileConstipationNonalcoholic Fatty Liver Disease (NAFLD) With History of Diabetes MelitusParkinson DiseaseParkinson's Disease
Phase 1
Characterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease Patients
WithdrawnNCT03026231
Start: 2017-07-15End: 2018-07-17Updated: 2018-08-10
Study of the Fecal Microbiome in Patients With Parkinson's Disease
CompletedNCT03671785
Start: 2019-05-15End: 2022-10-12Updated: 2023-05-24
Phase 2
A Prospective, Randomized, Placebo-Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Administration of Lyophilized PRIM-DJ2727 or Placebo Given Orally in Subjects With Nonalcoholic Fatty Liver Disease
WithdrawnNCT04371653
Start: 2023-12-01End: 2024-12-01Updated: 2024-05-14
Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis
RecruitingNCT04373473
Start: 2020-09-14End: 2027-12-31Target: 58Updated: 2026-03-09
Randomized Clinical Trial of Standard FMT Treatments
WithdrawnNCT04729790
Start: 2020-01-10End: 2022-04-30Updated: 2021-01-29
A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
RecruitingNCT06827977
Start: 2025-03-03End: 2028-06-30Target: 21Updated: 2026-07-08